Ignite Creation Date:
2024-05-05 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00003427
Status:
COMPLETED
Last Update Posted:
2013-06-26
First Post:
1999-11-01
Brief Title:
Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Small Intestine Cancer |
| Anal Cancer |
| Colorectal Cancer |
| Esophageal Cancer |
| Extrahepatic Bile Duct Cancer |
| Gallbladder Cancer |
| Gastric Cancer |
| Gastrointestinal Carcinoid Tumor |
| Liver Cancer |
| Pancreatic Cancer |
Keywords:
| Name | View |
|---|---|
| stage IV pancreatic cancer | View |
| stage IV colon cancer | View |
| stage IV gastric cancer | View |
| recurrent gastric cancer | View |
| recurrent pancreatic cancer | View |
| stage IV rectal cancer | View |
| recurrent colon cancer | View |
| recurrent rectal cancer | View |
| stage IV anal cancer | View |
| recurrent anal cancer | View |
| stage IV esophageal cancer | View |
| recurrent esophageal cancer | View |
| metastatic gastrointestinal carcinoid tumor | View |
| recurrent gastrointestinal carcinoid tumor | View |
| advanced adult primary liver cancer | View |
| recurrent adult primary liver cancer | View |
| unresectable gallbladder cancer | View |
| recurrent gallbladder cancer | View |
| unresectable extrahepatic bile duct cancer | View |
| recurrent extrahepatic bile duct cancer | View |
| recurrent small intestine cancer | View |